This statistic shows the expenditure on research and development of biotech company Amgen from 2020 to 2024, by category. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California. Amgen's R&D expenditure amounted to approximately six billion U.S. dollars in 2024. Of that amount, some 2.8 billion U.S. dollars were spent on later stage clinical programs.
* For commercial use only
Basic Account
Starter Account
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Everything on "Amgen" in one document: edited and divided into chapters, including detailed references.
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield
Vice President, Hearst Magazines
Overview
Financials
Products and regions
Competitors
Research and development
Further related statistics
* For commercial use only
Basic Account
Starter Account
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
